Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| VBI Vaccines Inc/BC | 200,000 | reported | 31 Jan 2019 | tx 6+1,703,571 |
| LAURIER INTERNATIONAL INC | 174,584 | reported | 15 Aug 2016 | tx 60+7,383,835−1,666,664 |
| LogicBio Therapeutics, Inc. | 10,869 | reported | 19 Dec 2019 | tx 11+1,822,384−2,611,665 |
| Keros Therapeutics, Inc. | 10,500 | reported | 04 Jun 2025 | tx 38+4,034,935−3,559,452 |
| SENESCO TECHNOLOGIES INC | 2,859 | reported | 30 Jan 2023 | tx 23+6,611,384 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 Jun 2025 | GRANT_AWARD | Keros Therapeutics, Inc. | 5,250 | 0.00 USD | |
| 04 Jun 2025 | GRANT_AWARD | Keros Therapeutics, Inc. | 10,500 | 0.00 USD | deriv |
| 30 May 2024 | GRANT_AWARD | Keros Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 06 Jun 2023 | GRANT_AWARD | Keros Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 30 Jan 2023 | GRANT_AWARD | SENESCO TECHNOLOGIES INC | 2,859 | 0.00 USD | deriv |
| 29 Nov 2022 | EXERCISE | Keros Therapeutics, Inc. | 1,914 | 0.00 USD | |
| 29 Nov 2022 | EXERCISE | Keros Therapeutics, Inc. | 3,539 | 0.00 USD | |
| 29 Nov 2022 | EXERCISE | Keros Therapeutics, Inc. | 1,723 | 0.00 USD | |
| 29 Nov 2022 | EXERCISE | Keros Therapeutics, Inc. | 1,914 | 0.00 USD | deriv |
| 29 Nov 2022 | EXERCISE | Keros Therapeutics, Inc. | 1,723 | 0.00 USD | deriv |
| 29 Nov 2022 | EXERCISE | Keros Therapeutics, Inc. | 3,539 | 0.00 USD | deriv |
| 15 Jun 2022 | GRANT_AWARD | SENESCO TECHNOLOGIES INC | 20,000 | 0.00 USD | deriv |
| 01 Jun 2022 | GRANT_AWARD | Keros Therapeutics, Inc. | 8,293 | 0.00 USD | deriv |
| 01 Jun 2021 | GRANT_AWARD | Keros Therapeutics, Inc. | 8,293 | 0.00 USD | deriv |
| 19 May 2021 | GRANT_AWARD | SENESCO TECHNOLOGIES INC | 20,000 | 0.00 USD | deriv |
| 13 May 2021 | PURCHASE | SENESCO TECHNOLOGIES INC | 1,280,624 | 1.35 USD | first after silence |
| 13 May 2021 | PURCHASE | SENESCO TECHNOLOGIES INC | 2,630,487 | 1.35 USD | |
| 13 May 2021 | PURCHASE | SENESCO TECHNOLOGIES INC | 1,422,222 | 1.35 USD | |
| 13 May 2021 | PURCHASE | SENESCO TECHNOLOGIES INC | 592,592 | 1.35 USD | |
| 20 May 2020 | GRANT_AWARD | SENESCO TECHNOLOGIES INC | 20,000 | 0.00 USD | deriv |
| 13 Apr 2020 | CONVERSION | Keros Therapeutics, Inc. | 1,363,542 | — | |
| 13 Apr 2020 | CONVERSION | Keros Therapeutics, Inc. | 663,825 | — | |
| 13 Apr 2020 | CONVERSION | Keros Therapeutics, Inc. | 737,226 | — | |
| 13 Apr 2020 | CONVERSION | Keros Therapeutics, Inc. | 169,307 | — | |
| 13 Apr 2020 | CONVERSION | Keros Therapeutics, Inc. | 82,425 | — |
3 purchases reported after at least 12 months of silence — most recent on 13 May 2021.